Hudson Therapeutics, Inc.
  • Home
  • About US
  • PIPELINE
  • INFLAMMASOME
  • NANOBODY
  • News
  • More
    • Home
    • About US
    • PIPELINE
    • INFLAMMASOME
    • NANOBODY
    • News
Hudson Therapeutics, Inc.
  • Home
  • About US
  • PIPELINE
  • INFLAMMASOME
  • NANOBODY
  • News

About US

 Hudson Therapeutics, Inc. was founded in February 2023 by Shaperon Inc., a KOSDAQ-listed biotech in Korea.

The founder, Dr. Shawn Y. Seong has a successful track record for new therapeutics development and for investors with the IPO of Shaperon in October 2022, a biotech company founded in Korea in 2008.

Hudson Therapeutics, Inc. is headquartered in Research Triangle Park, NC, and has an office in Cambridge, MA

Mission

 Enriching patients' quality of life is at the core of our purpose. We aim to enhance therapeutic potential through strategic innovation and adept development, ultimately contributing to patient well-being.  

Approaching

Hudson Therapeutics, Inc. operates at the forefront of pharmaceutical innovation. Our strategy is simple yet powerful: in-license promising assets, add value through an innovative development strategy and implementation, and out-license them to maximize their commercialization potential.  

Contact Us

Hudson Therapeutics, Inc.

Headquarter: 600 Park Office Drive, Durham, NC 27709, USA

Massachusetts Office:  3 Allied Drive, Suite 303, Dedham, MA 02026

Cambridge Office: 245 First Street, Riverview ll, 18th Fl, Cambridge, MA, 02142 

600 Park Offices Drive, Durham, North Carolina 27709, United States

E: peoples@HudsonTherapeutics.com

 © 2023 Hudson Therapeutics, Inc.

The information presented on this website is derived from the official website of our parent company, Shaperon, Inc. This site is designed exclusively to showcase Hudson Therapeutics, Inc. to potential investors and partners. Please note that we are not responsible for any misuse of the content outside its intended purpose.


Powered by

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

DeclineAccept